Moderna is set to receive $590m in funding from the US Department of Health and Human Services (HHS) to expedite the development of mRNA-based pandemic influenza vaccines. The initiative is part of a broader effort to enhance the US's preparedness for future infectious diseases.

The U.S. government has awarded Boston-based pharmaceutical company Moderna (MRNA) $590 million U.S. in new money to speed-up development of a vaccine against bird flu. The administration of outgoing U.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.